Standards; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:
(S)-2-((S)-2-Amino-4-phenylbutanamido)-4-methyl-N-((S)-1-(((R)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)pentanamide is an impurity of Carfilzomib (C183460), a second-generation proteasome inhibitor that is used as a treatment in relapsed and refractory multiple myeloma.